Yongjun Bian

Combination of Hua Shi Bai Du granule (Q-14) and standard care in the treatment of patients with coronavirus disease 2019 (COVID-19): A single-center, open-label, randomized controlled trial

Jia Liu, Wei Yang, Yue Liu et al. · Phytomedicine · 2021 · 70 citations · Full text

Coronavirus Disease 2019, Standard Care, Covid-19 Pandemic +6

Efficacy and safety of Chinese herbal medicine versus Lopinavir-Ritonavir in adult patients with coronavirus disease 2019: A non-randomized controlled trial

Nannan Shi, Lanping Guo, Bin Liu et al. · Phytomedicine · 2020 · 58 citations · Full text

Efficacy and safety assessment of severe COVID-19 patients with Chinese medicine: A retrospective case series study at early stage of the COVID-19 epidemic in Wuhan, China

Yu Wang, Cheng Lü, Hao Li et al. · Journal of Ethnopharmacology · 2021 · 48 citations · Full text

Virus Epidemiology, Medicine, Covid-19 Pandemic +7

The Impact of Depression and Anxiety on Chronic Obstructive Pulmonary Disease Acute Exacerbations: A prospective cohort study

Juan Huang, Yongjun Bian, Yuan-Chen Zhao et al. · Journal of Affective Disorders · 2020 · 44 citations

Psychological Co-morbidities, Psychiatry, Mood Symptom +6

Chinese Medicine Formula Huashibaidu Granule Early Treatment for Mild COVID-19 Patients: An Unblinded, Cluster-Randomized Clinical Trial

Zhao Chen, Li Li, Wei Yang et al. · Frontiers in Medicine · 2021 · 36 citations · Full text